CAH - Cardinal Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
51.63
+0.10 (+0.19%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Previous Close51.53
Open51.96
Bid48.20 x 27000
Ask58.00 x 2200
Day's Range51.06 - 51.99
52 Week Range48.14 - 75.75
Volume3,971,151
Avg. Volume3,440,509
Market Cap15.482B
Beta (3Y Monthly)1.28
PE Ratio (TTM)63.74
EPS (TTM)0.81
Earnings DateNov 5, 2018 - Nov 9, 2018
Forward Dividend & Yield1.91 (3.69%)
Ex-Dividend Date2018-09-28
1y Target Est54.93
Trade prices are not sourced from all markets
  • Analyzing Gilead Sciences’ Research Pipeline Developments
    Market Realist10 days ago

    Analyzing Gilead Sciences’ Research Pipeline Developments

    On October 3, Gilead Sciences (GILD) reported the results from a phase three study evaluating the safety and efficacy of Biktarvy for treating HIV-1 infections in treatment-naive patients. The drug was found to be statistically non-inferior to a regimen of abacavir, dolutegravir, and lamivudine through 96 weeks of therapy.

  • Women Pharmacist Day Spotlights Important Contributions, Accomplishments of Female Pharmacists
    PR Newswire12 days ago

    Women Pharmacist Day Spotlights Important Contributions, Accomplishments of Female Pharmacists

    DUBLIN, Ohio, Oct. 3, 2018 /PRNewswire/ -- The inaugural Women Pharmacist Day will be commemorated on Oct. 12, 2018, in conjunction with National Pharmacist Month, to recognize the important contributions women pharmacists make, every day, to delivering quality care to patients. While women made up only 8% of all U.S. pharmacists as recently as the 1960s, women currently comprise 55% of the pharmacist workforce, and the number of those practicing is on the rise.

  • How GlaxoSmithKline Stock Has Performed in September
    Market Realist17 days ago

    How GlaxoSmithKline Stock Has Performed in September

    GlaxoSmithKline (GSK), a global pharmaceutical company, is focused on creating a sustainable growth model through expanding its business beyond pharmaceuticals. GlaxoSmithKline reports its financial statements in sterling pounds. GlaxoSmithKline ADR fell marginally by ~0.1% as compared to its previous close to the closing price of $40.51 on September 27.

  • Pfizer’s Earnings Quality and Dividend Performance
    Market Realist18 days ago

    Pfizer’s Earnings Quality and Dividend Performance

    It announced its first-quarter interim dividend of $0.34 on December 18, 2017, and paid it on March 1, 2018. It announced its second-quarter interim dividend of $0.34 on April 26 and paid it on June 1. It announced its third-quarter interim dividend of $0.34 on June 28 and paid it on September 4.

  • Morningstar18 days ago

    Healthcare: Valuations Improve as Concerns Over Drug Pricing Pressures Begin to Abate

    Overall, healthcare valuations have slightly risen to a price/fair value of 1.07, up from 0.98 at the end of the second quarter and 1.04 at the start of the year, but the differences in industry valuations continue to suggest drug, biotech, and drug supply chain industries are the most undervalued areas. Innovative new drug launches combined with strong advancements in drug pipelines are supporting a steady growth outlook for the drug and biotech industries. Concerns around U.S. governmental reforms addressing drug pricing appear to be easing on the valuations for drug manufacturers with the majority of reform concerns still surrounding potential changes to the drug supply chain.

  • 10 Best Blue-Chip Stocks for Mid-Career Investors
    InvestorPlace20 days ago

    10 Best Blue-Chip Stocks for Mid-Career Investors

    Investment portfolios for this mid-career crowd are also at critical junctures. With that as the backdrop, here’s a look at ten blue-chip stocks to buy if you’re around the age of 40. Perhaps best of all, they’re names that don’t require constant baby-sitting, letting mid-career investors focus on other things like work, kids and aging parents.

  • An Intrinsic Calculation For Cardinal Health Inc (NYSE:CAH) Shows It’s 44.15% Undervalued
    Simply Wall St.25 days ago

    An Intrinsic Calculation For Cardinal Health Inc (NYSE:CAH) Shows It’s 44.15% Undervalued

    Today I will be providing a simple run through of a valuation method used to estimate the attractiveness of Cardinal Health Inc (NYSE:CAH) as an investment opportunity by taking theRead More...

  • Nevada prisons drug buyer knew firms opposed execution use
    Associated Presslast month

    Nevada prisons drug buyer knew firms opposed execution use

    Nevada's prisons pharmacy chief testified Wednesday that she obtained drugs for the lethal injection of a convicted killer despite knowing that drug manufacturers didn't want their products used for executions. Department of Corrections Pharmacy Director Linda Fox said during questioning by attorneys representing drug companies that she made the online order of medications from a third-party supplier, Cardinal Health, and didn't specify the end use. "Notwithstanding everything you knew coming into these three purchases about the industry, the publications, about the news, about the letters, the Department of Corrections ... honored none of those objections, is that right?" asked James Pisanelli, an attorney representing drug maker Alvogen.

  • CNBClast month

    85% of insured Amazon Prime members open to buying drugs on the site, Deutsche Bank says

    The vast majority of Amazon Prime members who have health insurance told Deutsche Bank that they would be willing to purchase prescription drugs on the online retailer's website.

  • InvestorPlacelast month

    Cardinal Health Stock Is Ready to Offer Healthy Profits for Investors

    After a downward trend for the stock price in 2018, investors may consider adding Cardinal Health (NYSE:CAH) stock to their portfolio for the rest of the year. There are several long strategies in CAH stock that could lead to impressive profits. The healthcare services and medical supplier Cardinal Health has paid handsome dividends over the past years with a current dividend yield of 3.6%.

  • Who Owns Cardinal Health Inc (NYSE:CAH)?
    Simply Wall St.2 months ago

    Who Owns Cardinal Health Inc (NYSE:CAH)?

    A look at the shareholders of Cardinal Health Inc (NYSE:CAH) can tell us which group is most powerful. Institutions often own shares in more established companies, while it’s not unusualRead More...

  • MDT’s Minimally Invasive Therapies’ Fiscal Q1 2019 Performances
    Market Realist2 months ago

    MDT’s Minimally Invasive Therapies’ Fiscal Q1 2019 Performances

    In the first quarter of fiscal 2019, Medtronic’s (MDT) Minimally Invasive Therapies Group reported revenue of $2.1 billion compared to $2.5 billion in the fiscal first quarter of 2018, reflecting a ~17% YoY (year-over-year) fall.

  • GuruFocus.com2 months ago

    Cardinal Health Inc (CAH) Files 10-K for the Fiscal Year Ended on June 30, 2018

    Cardinal Health Inc (NYSE:CAH) files its latest 10-K with SEC for the fiscal year ended on June 30, 2018.

  • Cardinal Health Product Spectrum Broad, Competition Rife
    Zacks2 months ago

    Cardinal Health Product Spectrum Broad, Competition Rife

    Cardinal Health's (CAH) strategic buyouts lend it a competitive edge; the Cordis unit lacks luster.

  • Reuters2 months ago

    Express Scripts staking out million-dollar gene therapies

    Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs. Express Scripts is in talks with biotechnology companies Biomarin Pharmaceutical Inc (BMRN.O), Spark Therapeutics Inc (ONCE.O) and Bluebird Bio Inc (BLUE.O) to have its specialty pharmaceutical business exclusively distribute their new haemophilia therapies when they are expected to become available in 2019 and 2020, Chief Medical Officer Steve Miller told Reuters in an interview.

  • GlobeNewswire2 months ago

    Recent Analysis Shows Automatic Data Processing, Denbury Resources, ITT, Cardinal Health, Geron, and The Hackett Group Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, Aug. 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Automatic ...

  • Cardinal Health Board of Directors Approves Quarterly Dividend
    PR Newswire2 months ago

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio , Aug. 8, 2018 /PRNewswire/ -- The Cardinal Health (NYSE: CAH) board of directors today approved a quarterly dividend of $0.4763 per share. The dividend will be payable on October 15, 2018 to ...

  • See what the IHS Markit Score report has to say about Cardinal Health Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Cardinal Health Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Services sector is rising.

  • 3 Value Plays That Won’t Cut Investors
    InvestorPlace2 months ago

    3 Value Plays That Won’t Cut Investors

    Nearly 10 years into the bull market, it’s getting progressively more difficult to find value in stocks. There are still good deals to be found, but value investors face the ever-present danger of trying to “catch a falling knife” and being cut as the shares fall further. #-ad_banner-#Learning how to catch the temporary discounts while avoiding the stocks with farther to fall comes down to finding the companies with the financial flexibility and strength to survive.